Canada - Toronto Stock Exchange - TSX:AIDX - CA42249X1006 - Common Stock
The current stock price of AIDX.CA is 0.92 CAD. In the past month the price decreased by -37.84%. In the past year, price decreased by -43.9%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL-DB.CA | WELL HEALTH TECHNOLOGIES | N/A | 25.39B | ||
| DNTL.CA | DENTALCORP HOLDINGS LTD | 20.62 | 2.09B | ||
| WELL.CA | WELL HEALTH TECHNOLOGIES COR | N/A | 977.63M | ||
| NLH.CA | NOVA LEAP HEALTH CORP | 30 | 26.19M | ||
| NPTH.CA | NEUPATH HEALTH INC | N/A | 23.03M | ||
| PHA.CA | PREMIER HEALTH OF AMERICA IN | N/A | 1.11M |
HealWELL AI, Inc. is a health care technology company, which focuses on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. The company is headquartered in Toronto, Ontario and currently employs 350 full-time employees. The company went IPO on 2007-04-25. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The firm's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere and Mutuo subsidiaries. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.
HEALWELL AI INC
4881 Yonge Street, Suite 300
TORONTO ONTARIO CA
Employees: 350
HealWELL AI, Inc. is a health care technology company, which focuses on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. The company is headquartered in Toronto, Ontario and currently employs 350 full-time employees. The company went IPO on 2007-04-25. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The firm's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere and Mutuo subsidiaries. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.
The current stock price of AIDX.CA is 0.92 CAD.
AIDX.CA does not pay a dividend.
AIDX.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
HEALWELL AI INC (AIDX.CA) operates in the Health Care sector and the Health Care Providers & Services industry.
HEALWELL AI INC (AIDX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.44).
You can find the ownership structure of HEALWELL AI INC (AIDX.CA) on the Ownership tab.
ChartMill assigns a fundamental rating of 2 / 10 to AIDX.CA. AIDX.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months AIDX.CA reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS increased by 43.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.17% | ||
| ROE | -92.69% | ||
| Debt/Equity | 0.4 |
17 analysts have analysed AIDX.CA and the average price target is 3.29 CAD. This implies a price increase of 258.11% is expected in the next year compared to the current price of 0.92.
For the next year, analysts expect an EPS growth of 56.97% and a revenue growth 243.72% for AIDX.CA